Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Longitudinal monitoring of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC).
Authors
Yoojoo Lim
IMBdx, Seoul, South Korea
Yoojoo Lim , Sheehyun Kim , Jun-Kyu Kang , Hwang-Phill Kim , Hanseong Roh , Su Yeon Kim , Dongin Lee , Duhee Bang , Seung-Yong Jeong , Kyu Joo Park , Sae-Won Han , Tae-You Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.189
Abstract #
189
Poster Bd #
J8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
CRISPincette, and detection of low frequency cancer mutations in ctDNA.
First Author: Jin-Soo Kim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
First Author: Tom Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Use of tumor-informed ctDNA across gastrointestinal cancers.
First Author: Matthew Reilley
Poster
2023 ASCO Annual Meeting
Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?
First Author: Jonathan M. Loree